Skip to main content
Premium Trial:

Request an Annual Quote

Berlex Expands License to Biotique s BLIS Platform

NEW YORK, Jan. 19 (GenomeWeb News) - Berlex Biosciences, the US affiliate of Schering, has expanded its license to Biotique Systems' BLIS platform, Biotique said today.

 

Berlex obtained a three-year license to the Biotique Local Integration System that provides worldwide access to Schering's research operations. Under a previous agreement, Berlex had licensed BLIS for its research site in Richmond, Calif.

 

Biotique, based in Emeryville, Calif., offers BLIS as a framework for biological data integration. Its customers include Merck, Bristol-Myers Squibb, Monsanto, and Affymetrix.

 

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.